Health TrialsbyHealthPanel

Intra-Corporeal Anastomosis Result in Quicker Return of Bowel Function/Earlier Discharge

ConditionColorectal Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCorewell Health West

About this trial

Adult patients who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Eligible patients are those over 18 years of age who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis. Right colectomy will be defined as removal of the ascending colon, ligation of the ileocolic artery and vein, +/- removal of the terminal ileum, +/- removal of the proximal transverse colon, and +/- removal of the right branch of the middle colic artery and vein.

Disqualifiers

Pregnant women

Additional colon resection is planned (i.e. left colectomy or proctectomy)

Vulnerable populations such as prisoners or adults unable to give consent

If the scheduled surgery is planned at Butterworth hospital (as to standardize the nursing care received postoperatively)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Right Hemicolectomy

    Procedure/Surgery

    Minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis.

Treatment groups

125 Participants
are divided into 2 treatment groups
Group A: Intra-corporealOther 1 intervention
Group B: Extra-corporealOther 1 intervention

Trial outcomes

Primary outcomes

1

Return of bowel function

Flatus and bowel motions

Time frame
up to 2 weeks

Secondary outcomes

1

Inpatient length of stay

Days in the hospital after surgery

Time frame
up to 2 weeks
2

Incision length

cm's

Time frame
Surgery date
3

Postoperative narcotic use

Average pain scores over first 5 hospital days

Time frame
up to 2 weeks
4

Surgical site infection

(superficial, deep and organ-space)

Time frame
up to 6 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Corewell Health West

Lead sponsor

Source ClinicalTrials.gov
Apply now